Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,001–1,025 of 7,816 matching trials · page 41 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease NCT00646269 Standard intervention protocol; Standard intervention protocol + Co... Runs in: France · 39 sites |
PHASE3 other |
COMPLETED | 640 | University Hospital, Bordeaux OTHER |
2026-05-14 |
|
Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II) NCT00914095 methylphenidate; placebo Runs in: France · 1 site |
PHASE4 other |
COMPLETED | 69 | University Hospital, Lille OTHER |
2026-05-14 |
|
Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies NCT00917709 Imaging with IBVM; Imaging with DATSCAN; neuropsychological evaluation Runs in: France · 1 site |
NA other |
COMPLETED | 34 | University Hospital, Bordeaux OTHER |
2026-05-14 |
|
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease NCT01108029 memantine; placebo Runs in: France · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 28 | University Hospital, Lille OTHER |
2026-05-14 |
|
Retinal Neurodegenerative Signs in Alzheimer's Diseases NCT01555827 Ophthalmological examination & Questionnaire Runs in: France · 1 site |
NA other |
COMPLETED | 200 | University Hospital, Bordeaux OTHER |
2026-05-14 |
|
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study NCT01582919 Neuroimaging Runs in: France · 1 site |
NA other |
COMPLETED | 304 | University Hospital, Bordeaux OTHER |
2026-05-14 |
|
Animal-Assisted Therapy for People With Dementia NCT03946696 Interactions with therapy-animals Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 20 | University of Aberdeen OTHER |
2026-05-14 |
|
Nonverbal Communication in Aged People NCT04146688 Music Balance Board Runs in: France · 1 site |
NA other |
COMPLETED | 240 | University Hospital, Lille OTHER |
2026-05-14 |
|
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease NCT04840979 11C-ER176; 18F-florbetaben Runs in: United States · 1 site |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 107 | Columbia University OTHER |
2026-05-14 |
|
"Safety in Dementia": An Online Caregiver Intervention NCT05173922 Safety in Dementia Runs in: United States · 1 site |
NA other |
COMPLETED | 500 | University of Colorado, Denver OTHER |
2026-05-14 |
|
Improving Physical Activity With Cognitive Impairment NCT05370118 Telerehabilitation physical activity behavioral (TPAB) intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | Creighton University OTHER |
2026-05-14 |
|
A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease NCT05541627 AB-1001 Gene Therapy Runs in: France · 1 site |
PHASE1|PHASE2 gene-therapy |
ACTIVE_NOT_RECRUITING | 5 | AskBio France, SAS, a subsidiary of AskBio Inc. INDUSTRY |
2026-05-14 |
|
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD NCT06055322 Adapted Dialectical Behavior Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 9 | Texas Tech University OTHER |
2026-05-14 |
|
Predictors Of Cognitive Decline Using Digital Devices NCT07051408 Runs in: United Kingdom · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 135 | University College, London OTHER |
2026-05-14 |
|
Tele-Savvy for Latino Caregivers NCT07290387 Tele Savvy for Latino Caregivers Runs in: United States · 1 site |
NA other |
RECRUITING | 64 | University of Rochester OTHER |
2026-05-14 |
|
Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy NCT07394504 Turning Based Dual Task Training; Dual-Task Training Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 50 | Foundation University Islamabad OTHER |
2026-05-14 |
|
Long-term Prospective Study of Korean CADASIL Patients NCT07497867 Runs in: South Korea · 1 site |
NA other |
RECRUITING | 500 | Jeju National University Hospital OTHER |
2026-05-14 |
|
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy NCT07580703 [18F]Flortaucipir Injection Runs in: China · 1 site |
PHASE1 other |
RECRUITING | 18 | Eli Radiopharma INDUSTRY |
2026-05-14 |
|
China-NINE Cohort:Neuroimmune Network in Elderly / Neurodegeneration NCT07586501 Runs in: China · 2 sites |
NA other |
ENROLLING_BY_INVITATION | 260 | Yantai Yuhuangding Hospital OTHER |
2026-05-14 |
|
Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial) NCT03317067 Dexmedetomidine; Placebo Runs in: France · 1 site |
PHASE3 other |
COMPLETED | 168 | University Hospital, Clermont-Ferrand OTHER |
2026-05-13 |
|
Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease NCT05785156 quick tests Runs in: France · 1 site |
NA other |
RECRUITING | 129 | Centre Hospitalier Universitaire, Amiens OTHER |
2026-05-13 |
|
North American Prodromal Synucleinopathy Consortium Stage 2 NCT05826457 Runs in: Canada; United States · 9 sites |
NA other |
ENROLLING_BY_INVITATION | 500 | Washington University School of Medicine OTHER |
2026-05-13 |
|
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients NCT06199037 SHR-1707; SHR-1707 placebo Runs in: China · 1 site |
PHASE2 other |
TERMINATED | 46 | Shanghai Hengrui Pharmaceutical Co., Ltd. INDUSTRY |
2026-05-13 |
|
Cardiac-Control Affecting Learning Through Mindfulness (CALM) NCT06410157 Daily practice Runs in: United States · 1 site |
NA other |
RECRUITING | 240 | University of Southern California OTHER |
2026-05-13 |
|
Swedish Palliative Care Guide (S-PCG) at Nursing Homes NCT06431659 Runs in: Sweden · 1 site |
NA other |
ENROLLING_BY_INVITATION | 400 | Region Skane OTHER |
2026-05-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial